Novartis Posted July 9, 2026

Principal Scientist, Early Pipeline Development

LaJolla/SD, United States Regular
Principal

Novartis is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

We are seeking a highly motivated Principal Scientist I with extensive AAV gene therapy manufacturing experience to develop state-of-the art downstream purification processes for next-generation AAV gene therapy.  This role is also responsible for executing early-stage process development with the focus on developability of AAV gene therapy lead candidates as well as new platform process development for existing and novel AAV capsids and cargo vectors.

Internal Job Title: Principal Scientist I/IIPosition Location: Onsite, San Diego, CAKey Responsibilities:Lead and manage a 3-5 person downstream process team and provide technical support, training, and SME knowledge to assist with the professional development of direct reports.Coordinate activities with associates across upstream process and analytical teams.Develop strategies in collaboration with Disease Areas and partner with various line functions to support early drug discovery from target selection and validation through lead compound selection and developability assessment.Serve as a subject matter expert to transfer manufacturing process knowledge to Technical Research & Development team and advance pipeline programs into clinical phases.Lead effort and work collaboratively with Technical Research & Development to develop innovative and cost-effective downstream processes for next-generation AAV.Manage multiple project workflow to ensure timely delivery.Prepare written reports conforming to defined documentation practices including electronic lab notebook.Other related duties as assigned.Essential Requirements:PhD in bioprocessing, biochemical engineering, gene therapy or a related field with 3+ years of relevant process development experience in biotechnology/ pharmaceutical environment.Experience in people managementKnowledge of downstream purification processes including affinity and ion-exchange chromatography with hands on experience with AKTA purification systems.Technical proficiency, creativity, and independent thoughtsEffective communication skills to convey scientific concepts to research scientists and cross-functional collaborators.Strong organization and problem-solving skills with attention to details.Ability to work in a fast-paced and matrix environment.Desired Requirements:Experiences in AAV gene therapyExperience with viral gene therapyThe salary for this position is expected to range between $108,500 and $201,500 per year for Principal Scientist I, and between $119,700 and $222,300 per year for Principal Scientist II. The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors.Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.To learn more about the culture, rewards and benefits we offer our people click here.

Job details

Seniority
Principal
Function
Not listed
Therapeutic area
Not listed
Location
LaJolla/SD, United States
Employment type
Regular

How this role compares

Computed from every other active role in our database, not just this employer's listings.

We don't have enough classified peer data for this role yet, so there's no comparison to show. This happens when a posting's title/category doesn't match any taxonomy rule -- it's excluded rather than compared against the wrong peer group.